Earlier quoted context omitted.
It seems the insurance company was happy to pay for treatment that wouldn't work though (the approved treatment had already been tried), they denied a treatment that was working.
One costs $60/year, the other is over $2M/year and not tested and not widely used outside the US
Remicade is available in (at least) these countries: - US - Japan - Europe - Turkey - Russia
Entyvio: - US - Europe - Canada - Japan - Australia
Biologics are the first line of defense for anything over mild IBD. The only effective treatment for above moderate that isn't a combination of other meds is Rinvoq. The small dose items like Azith and Pred are just for flare management, and aren't maintenance medications.